West Pharmaceutical Servs Q2 2024 Adj EPS $1.52 Misses $1.74 Estimate, Sales $702.100M Miss $729.350M Estimate
Portfolio Pulse from Benzinga Newsdesk
West Pharmaceutical Services reported Q2 2024 adjusted EPS of $1.52, missing the estimate of $1.74. Sales were $702.1 million, also missing the estimate of $729.35 million.
July 25, 2024 | 10:01 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
West Pharmaceutical Services reported lower-than-expected Q2 2024 earnings and sales, with adjusted EPS of $1.52 missing the $1.74 estimate and sales of $702.1 million missing the $729.35 million estimate.
The company's earnings and sales both missed analyst estimates, which is likely to negatively impact the stock price in the short term as investors react to the disappointing financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100